The Role of Lipid Metabolism Disorders in the Development of Thyroid Cancer

Int J Mol Sci. 2024 Jun 28;25(13):7129. doi: 10.3390/ijms25137129.

Abstract

Thyroid cancer (TC) is a neoplasm with an increasing incidence worldwide. Its etiology is complex and based on a multi-layered interplay of factors. Among these, disorders of lipid metabolism have emerged as an important area of investigation. Cancer cells are metabolically reprogrammed to promote their rapid growth, proliferation, and survival. This reprogramming is associated with significant changes at the level of lipids, mainly fatty acids (FA), as they play a critical role in maintaining cell structure, facilitating signaling pathways, and providing energy. These lipid-related changes help cancer cells meet the increased demands of continued growth and division while adapting to the tumor microenvironment. In this review, we examine lipid metabolism at different stages, including synthesis, transport, and oxidation, in the context of TC and the effects of obesity and hormones on TC development. Recent scientific efforts have revealed disturbances in lipid homeostasis that are specific to thyroid cancer, opening up potential avenues for early detection and targeted therapeutic interventions. Understanding the intricate metabolic pathways involved in FA metabolism may provide insights into potential interventions to prevent cancer progression and mitigate its effects on surrounding tissues.

Keywords: fatty acid oxidation; fatty acids uptake; hormones; lipid metabolism; obesity; thyroid cancer.

Publication types

  • Review

MeSH terms

  • Animals
  • Fatty Acids / metabolism
  • Humans
  • Lipid Metabolism Disorders / metabolism
  • Lipid Metabolism*
  • Obesity / metabolism
  • Signal Transduction
  • Thyroid Neoplasms* / etiology
  • Thyroid Neoplasms* / metabolism
  • Thyroid Neoplasms* / pathology
  • Tumor Microenvironment

Substances

  • Fatty Acids

Grants and funding

This research was funded by the NCN grant MINIATURA 2022/06/X/NZ4/00037, and the Medical University of Gdansk grant number 01/50024/0006142/002/501/501/2024 and 01-10023/0004991/01/119/119/2024.